PMID: 7545769Sep 23, 1995Paper

Depletion of myelin-basic-protein autoreactive T cells by T-cell vaccination: pilot trial in multiple sclerosis

Lancet
R MedaerJ Zhang

Abstract

In a pilot trial, eight patients with multiple sclerosis were matched to control patients and received T-cell vaccination with irradiated T cells reactive to myelin basic protein (MBP) to deplete circulating MBP-reactive T cells. In the 2 years before and after vaccination, exacerbations decreased in five vaccinated patients (numbers 1, 2, 6-8) with relapsing-remitting disease from sixteen to three, respectively, and from twelve to ten in their matched controls. Magnetic resonance imaging showed a mean 8.0% increase in brain lesion size in the vaccinated patients compared with a 39.5% increase in the controls. Lesions and/or relapses worsened in three cases after vaccination in association with reappearance of circulating MBP-reactive T cells.

References

Jan 1, 1992·International Reviews of Immunology·J ZhangD A Hafler

❮ Previous
Next ❯

Citations

Feb 21, 2013·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Dimitrios Karussis
Nov 11, 1999·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·J A Castelijns, F Barkhof
Nov 13, 2001·Trends in Immunology·V KumarI Cohen
Feb 12, 2004·Autoimmunity Reviews·Anat Achiron, Mathilda Mandel
Nov 1, 2008·Nature Reviews. Drug Discovery·Rocio S Lopez-Diego, Howard L Weiner
Mar 19, 1996·Proceedings of the National Academy of Sciences of the United States of America·L Steinman
May 4, 1999·Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis·M NoguchiT Toyota
Jul 27, 1999·Annals of the Rheumatic Diseases·W A van der ReijdenA V Amerongen
Jan 22, 2005·Annual Review of Medicine·Jingwu Zhang, George Hutton
Oct 3, 2001·The Journal of Clinical Investigation·A D SalamaM H Sayegh
Apr 12, 2012·Journal of the American Society of Nephrology : JASN·Yuan Min WangStephen I Alexander
Jul 10, 2002·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Heinz Wiendl, Reinhard Hohlfeld
Jul 10, 2008·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Arthur A Vandenbark, Rivka Abulafia-Lapid
Jul 10, 2003·Lancet Neurology·Gianvito MartinoMassimo Filippi
Mar 21, 2006·Proceedings of the National Academy of Sciences of the United States of America·Jian HongJingwu Z Zhang
Aug 13, 2004·Proceedings of the National Academy of Sciences of the United States of America·Reinhard Hohlfeld, Hartmut Wekerle
Aug 7, 2014·Clinical Reviews in Allergy & Immunology·Xin HuangQianjin Lu
Jun 16, 2000·Journal of Neuroimmunology·J CorrealeL P Weiner
Dec 20, 2002·Nature·Howard L Weiner, Dennis J Selkoe
Nov 14, 2015·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Stefan Bittner, Heinz Wiendl
Aug 1, 1997·Mayo Clinic Proceedings·S F HunterJ H Noseworthy
Jul 5, 2008·Journal of the Neurological Sciences·Andreas LutterottiRoland Martin
Jul 4, 2007·Revue neurologique·E Waubant
Oct 7, 2015·Journal of the Neurological Sciences·Mojtaba FarjamAbdolmohamad Rostami
Jun 15, 2007·European Journal of Immunology·Yuhong YangMichael K Racke
Feb 1, 2007·Arthritis and Rheumatism·Guangjie ChenJingwu Z Zhang
May 14, 2011·Expert Opinion on Biological Therapy·Victor M Rivera
Jun 9, 2005·Expert Review of Neurotherapeutics·Ee Tuan Lim, Gavin Giovannoni
Dec 2, 2005·International Reviews of Immunology·Mireia Sospedra, Roland Martin
Sep 12, 2002·Expert Opinion on Therapeutic Targets·Trevor Owens
Jul 2, 2005·Expert Opinion on Investigational Drugs·E G Spack
Oct 25, 2013·Expert Opinion on Investigational Drugs·Andreas Lutterotti, Roland Martin
Apr 1, 2003·Expert Opinion on Investigational Drugs·Heinz Wiendl, Bernd C Kieseier
Apr 16, 2004·The Journal of Clinical Investigation·Vily PanoutsakopoulouHarvey Cantor
May 19, 2016·Expert Review of Clinical Immunology·Vikram Bhise, Suhayl Dhib-Jalbut
Jul 13, 2004·Autoimmunity Reviews·Niels HellingsPiet Stinissen
Sep 29, 2004·Clinical Immunology : the Official Journal of the Clinical Immunology Society·A AchironM Mandel
Jan 5, 2006·Autoimmunity·Erica Lee, Animesh A Sinha

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.